Feb 12, 2026 08:04AM
Feb 12, 2026 08:00AM
Jan 29, 2026 08:00AM
Jan 11, 2026 05:00PM
Nov 4, 2025 06:51AM
Oct 30, 2025 08:02AM
Oct 30, 2025 08:00AM Alnylam Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Period Progress
Oct 27, 2025 07:41AM
Oct 17, 2025 08:32AM
Oct 16, 2025 08:00AM
Oct 12, 2025 03:00PM
Aug 1, 2025 07:45AM
Jul 31, 2025 08:02AM
Jul 31, 2025 08:00AM Alnylam Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Period Progress
Jul 17, 2025 08:27AM
Jul 17, 2025 08:00AM
Jul 16, 2025 07:18AM
May 6, 2025 07:13AM
May 1, 2025 08:01AM
May 1, 2025 08:00AM
Apr 17, 2025 08:00AM Alnylam to Webcast Conference Call Discussing First Quarter 2025 Financial Results
Apr 12, 2025 04:00AM
Mar 31, 2025 04:16AM
Feb 25, 2025 06:45AM
Feb 13, 2025 08:03AM
Feb 13, 2025 08:00AM
Feb 3, 2025 05:11AM
Jan 30, 2025 08:00AM Alnylam to Webcast Conference Call Discussing Fourth Quarter and Full Year 2024 Financial Results
Jan 13, 2025 11:20AM
Jan 12, 2025 04:00PM
Nov 4, 2024 06:50AM
Oct 31, 2024 08:05AM
Oct 31, 2024 08:00AM
Oct 17, 2024 08:00AM
Aug 2, 2024 07:00AM Alnylam Pharmaceuticals (ALNY) PT Raised to $366 at Canaccord Genuity
Aug 1, 2024 08:14AM
Aug 1, 2024 08:00AM
Jul 18, 2024 08:00AM
Jul 9, 2024 07:00PM
May 2, 2024 08:03AM
May 2, 2024 08:00AM
Apr 18, 2024 08:00AM Alnylam to Webcast Conference Call Discussing First Quarter 2024 Financial Results
Feb 15, 2024 11:22AM
Feb 15, 2024 08:05AM
Feb 15, 2024 08:00AM
Jan 29, 2024 08:00AM
Jan 8, 2024 05:23AM
Jan 7, 2024 06:00PM
Nov 2, 2023 08:06AM Alnylam Pharma (ALNY) Tops Q3 EPS by $3.06
Nov 2, 2023 08:00AM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All